• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从腹水肉瘤180的无细胞液中纯化和鉴定一种脂解因子(毒素激素-L)。

Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180.

作者信息

Masuno H, Yamasaki N, Okuda H

出版信息

Cancer Res. 1981 Jan;41(1):284-8.

PMID:7448767
Abstract

A lipolytic substance in the ascites fluid of mice with Sarcoma 180, called toxohormone-L, was purified and characterized. The lipolytic activity of toxohormone-L was measured in vitro using rat adipose tissue slices. Toxohormone-L, purified approximately 90-fold from the ammonium sulfate fraction, gave a single band on polyacrylamide gel electrophoresis. Its molecular weight was about 75,000, and its isoelectric point was 4.7. Toxohormone-L is heat labile and nondialyzable, but, on its digestion with trypsin, an active fragment that was heat stable and dialyzable was produced. Toxohormone-L is a protein and is also present in the ascites fluid of patients with hepatoma and Grawitz's tumor.

摘要

从患有肉瘤180的小鼠腹水中纯化并鉴定出一种名为毒素激素-L的脂解物质。使用大鼠脂肪组织切片在体外测量毒素激素-L的脂解活性。从硫酸铵级分中纯化约90倍的毒素激素-L在聚丙烯酰胺凝胶电泳上呈现单一谱带。其分子量约为75,000,等电点为4.7。毒素激素-L对热不稳定且不可透析,但在用胰蛋白酶消化时,会产生一种对热稳定且可透析的活性片段。毒素激素-L是一种蛋白质,也存在于肝癌和肾上腺皮质瘤患者的腹水中。

相似文献

1
Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180.从腹水肉瘤180的无细胞液中纯化和鉴定一种脂解因子(毒素激素-L)。
Cancer Res. 1981 Jan;41(1):284-8.
2
Isolation of a lipolytic factor (toxohormone-L) from ascites fluid of patients with hepatoma and its effect on feeding behavior.
Eur J Cancer Clin Oncol. 1984 Sep;20(9):1177-85. doi: 10.1016/0277-5379(84)90127-5.
3
Purification of toxohormone.
Gan. 1972 Oct;63(5):605-13.
4
Solubilization and purification of bone morphogenetic protein (BMP) from Dunn osteosarcoma.
Clin Orthop Relat Res. 1980 Nov-Dec(153):232-40.
5
Purification and characterization of a nuclear DNA-binding phosphoprotein in fetal and tumor tissues.胎儿及肿瘤组织中一种核DNA结合磷蛋白的纯化与特性分析
Cancer Res. 1981 Feb;41(2):537-45.
6
[Inhibitive effect of umbellatus polyporus polysaccharide on cachexic manifestation induced by toxohormone-L in rats].[猪苓多糖对大鼠毒激素-L诱导恶病质表现的抑制作用]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Apr;17(4):232-3.
7
Lipolysis induction in adipocytes by a protein from tumor cells.肿瘤细胞中的一种蛋白质诱导脂肪细胞发生脂解作用。
J Cell Biochem. 1982;20(4):409-16. doi: 10.1002/jcb.240200410.
8
Molecular transformation of tumor adenylosuccinate synthetase and characteristics of its converting factor.肿瘤腺苷酸琥珀酸合成酶的分子转化及其转化因子的特性
Cancer Res. 1982 Jan;42(1):112-6.
9
[Demonstration and characterization of tumor-associated antigenic components from cell membranes of a UV-induced murine sarcoma using the MEM technic].[使用MEM技术对紫外线诱导的小鼠肉瘤细胞膜上肿瘤相关抗原成分的演示与表征]
Acta Biol Med Ger. 1980;39(2-3):315-25.
10
Purification and characterization of cytosol protein 45/7.8 present in rapidly growing hepatomas.快速生长型肝癌中存在的胞质溶胶蛋白45/7.8的纯化与特性分析
Cancer Res. 1980 May;40(5):1623-9.

引用本文的文献

1
Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer.结直肠癌患者血浆和红细胞脂肪酸谱的异常。
Br J Cancer. 1998 Jun;77(11):1978-83. doi: 10.1038/bjc.1998.328.
2
Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues.外周组织肿瘤中乙酰乙酸辅酶A转移酶活性丧失。
Br J Cancer. 1983 Feb;47(2):293-7. doi: 10.1038/bjc.1983.38.
3
Turnover and fate of plasma free fatty acids in briefly-fasted lymphoma-bearing mice.短期禁食的荷淋巴瘤小鼠血浆游离脂肪酸的周转率和去向
Lipids. 1989 Dec;24(12):1028-34. doi: 10.1007/BF02544074.
4
Alterations in serum lipolytic activity of cancer patients with response to therapy.对治疗有反应的癌症患者血清脂解活性的改变。
Br J Cancer. 1990 Nov;62(5):822-5. doi: 10.1038/bjc.1990.385.
5
Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients.恶病质癌症患者体重减轻时血清和尿液脂解活性的改变。
Br J Cancer. 1990 Nov;62(5):816-21. doi: 10.1038/bjc.1990.384.
6
Cancer cachexia.癌症恶病质
Int J Pancreatol. 1990 Aug-Nov;7(1-3):141-50. doi: 10.1007/BF02924231.
7
Lipid mobilising factors specifically associated with cancer cachexia.与癌症恶病质特异性相关的脂质动员因子。
Br J Cancer. 1991 Jun;63(6):846-50. doi: 10.1038/bjc.1991.188.
8
Cancer cachexia.癌症恶病质
Br J Cancer. 1991 Mar;63(3):337-42. doi: 10.1038/bjc.1991.80.
9
Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease.良性和恶性前列腺疾病患者血浆及组织磷脂中的必需脂肪酸分布情况
Br J Cancer. 1991 Dec;64(6):1157-60. doi: 10.1038/bjc.1991.481.
10
Purification of ornithine decarboxylase-inducing factor from cell-free ascites fluid of Ehrlich ascites tumor and its characteristics.从艾氏腹水瘤无细胞腹水中纯化鸟氨酸脱羧酶诱导因子及其特性
Jpn J Cancer Res. 1991 Mar;82(3):315-24. doi: 10.1111/j.1349-7006.1991.tb01848.x.